» Articles » PMID: 26120838

Placental Features of Late-Onset Adverse Pregnancy Outcome

Overview
Journal PLoS One
Date 2015 Jun 30
PMID 26120838
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Currently, no investigations reliably identify placental dysfunction in late pregnancy. To facilitate the development of such investigations we aimed to identify placental features that differ between normal and adverse outcome in late pregnancy in a group of pregnancies with reduced fetal movement.

Methods: Following third trimester presentation with reduced fetal movement (N = 100), placental structure ex vivo was measured. Placental function was then assessed in terms of (i) chorionic plate artery agonist responses and length-tension characteristics using wire myography and (ii) production and release of placentally derived hormones (by quantitative polymerase chain reaction and enzyme linked immunosorbant assay of villous tissue and explant conditioned culture medium).

Results: Placentas from pregnancies ending in adverse outcome (N = 23) were ~25% smaller in weight, volume, length, width and disc area (all p<0.0001) compared with those from normal outcome pregnancies. Villous and trophoblast areas were unchanged, but villous vascularity was reduced (median (interquartile range): adverse outcome 10 (10-12) vessels/mm2 vs. normal outcome 13 (12-15), p = 0.002). Adverse outcome pregnancy placental arteries were relatively insensitive to nitric oxide donated by sodium nitroprusside compared to normal outcome pregnancy placental arteries (50% Effective Concentration 30 (19-50) nM vs. 12 (6-24), p = 0.02). Adverse outcome pregnancy placental tissue contained less human chorionic gonadotrophin (20 (11-50) vs. 55 (24-102) mIU/mg, p = 0.007) and human placental lactogen (11 (6-14) vs. 27 (9-50) mg/mg, p = 0.006) and released more soluble fms-like tyrosine kinase-1 (21 (13-29) vs. 5 (2-15) ng/mg, p = 0.01) compared with normal outcome pregnancy placental tissue.

Conclusion: These data provide a description of the placental phenotype of adverse outcome in late pregnancy. Antenatal tests that accurately reflect elements of this phenotype may improve its prediction.

Citing Articles

Intraplacental Villous Artery Doppler can Improve the Ability to Predict Placenta-Mediated Disease.

Tudor A, Novac L, Camen I, Manolea M, Vrabie S, Sandulescu M Curr Health Sci J. 2023; 49(1):96-101.

PMID: 37780194 PMC: 10541068. DOI: 10.12865/CHSJ.49.01.96.


Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction.

Renshall L, Beards F, Evangelinos A, Greenwood S, Brownbill P, Stevens A Pharmaceutics. 2021; 13(11).

PMID: 34834193 PMC: 8618188. DOI: 10.3390/pharmaceutics13111778.


Modelling the Human Placental Interface In Vitro-A Review.

Cherubini M, Erickson S, Haase K Micromachines (Basel). 2021; 12(8).

PMID: 34442506 PMC: 8398961. DOI: 10.3390/mi12080884.


Toxicity of anticancer drugs in human placental tissue explants and trophoblast cell lines.

Eliesen G, Van Hove H, Meijer M, van den Broek P, Pertijs J, Roeleveld N Arch Toxicol. 2020; 95(2):557-571.

PMID: 33083868 PMC: 7870638. DOI: 10.1007/s00204-020-02925-w.


Standard care informed by the result of a placental growth factor blood test versus standard care alone in women with reduced fetal movement at or after 36 weeks' gestation: a pilot randomised controlled trial.

Armstrong-Buisseret L, Godolphin P, Bradshaw L, Mitchell E, Ratcliffe S, Storey C Pilot Feasibility Stud. 2020; 6:23.

PMID: 32082609 PMC: 7020549. DOI: 10.1186/s40814-020-0561-z.


References
1.
Roje D, Zekic Tomas S, Prusac I, capkun V, Tadin I . Trophoblast apoptosis in human term placentas from pregnancies complicated with idiopathic intrauterine growth retardation. J Matern Fetal Neonatal Med. 2011; 24(5):745-51. DOI: 10.3109/14767058.2010.526158. View

2.
Doctor B, ORiordan M, Kirchner H, Shah D, Hack M . Perinatal correlates and neonatal outcomes of small for gestational age infants born at term gestation. Am J Obstet Gynecol. 2001; 185(3):652-9. DOI: 10.1067/mob.2001.116749. View

3.
Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

4.
Biswas S, Ghosh S . Gross morphological changes of placentas associated with intrauterine growth restriction of fetuses: a case control study. Early Hum Dev. 2007; 84(6):357-62. DOI: 10.1016/j.earlhumdev.2007.09.017. View

5.
Yung H, Calabrese S, Hynx D, Hemmings B, Cetin I, Charnock-Jones D . Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol. 2008; 173(2):451-62. PMC: 2475782. DOI: 10.2353/ajpath.2008.071193. View